Stress can cause damage and atrophy of neurons in the hippocampus by deregulating the expression of neurotrophic factors that promote neuronal plasticity. The endocannabinoid system represents a physiological substrate involved in neuroprotection at both cellular and emotional levels. The lack of CB 1 receptor alters neuronal plasticity and originates an anxiety-like phenotype in mice. In the present study, CB 1 knockout mice exhibited an augmented response to stress revealed by the increased despair behavior and corticosterone levels showed in the tail suspension test and decreased brain derived neurotrophic factor (BDNF) levels in the hippocampus.
Introduction
Stressful events induce neurotrophins activation in the brain that is hypothesized to provide protection against neuronal damage and to stimulate sprouting and synaptic reorganization, enabling neural networks to cope with these stimuli (Lindvall et al, 1994) . However, prolonged and severe stress exposure can lead to neuronal atrophy and cell loss by inducing neurotrophic impairment in key limbic regions controlling emotional responses (Duman and Monteggia, 2006) . Limbic system regulates the hypothalamic-pituitary-adrenal (HPA) axis activity through inhibitory inputs from the hippocampus and the frontal cortex and stimulatory action from the amygdala, participating in the appropriate response to stress (Herman et al, 2005) . Among these brain structures, the hippocampus is particularly sensitive to stress-induced alterations due to the high density of glucocorticoid receptors in this specific brain region (McEwen, 1999) . In this sense, sustained elevations of glucocorticoids can induce damage in hippocampal neurons by reducing dendrite branching and the number of dendritic spines (Sapolsky, 2000a) . Therefore, these changes in synaptic connectivity of hippocampal neurons induced by stress might reduce the inhibitory control that this structure exerts on the HPA axis, leading to a positive feedback process with pathological consequences, such as hippocampal volume reduction and cognitive impairments (Radley and Morrison, 2005; Bremner, 2006) .
Brain derived neurotrophic factor (BDNF) is one of the most prevalent factors that modulates plasticity and survival of adult neurons (Huang and Reichardt, 2001 ). Several pre-clinical and clinical evidence demonstrate that BDNF plays a role in the pathophysiology of stress-related mood disorders (Duman and Monteggia, 2006) . The expression of BDNF is partially regulated by the transcription factor cAMP responsive 3 Aso et al element-binding (CREB) (Conti et al, 2002) , which represents a central integrator of signaling from a number of extracellular stimuli that influence neuronal plasticity and survival (Duman, 2002) . Most neuronal effects of BDNF are mediated through the highaffinity tyrosine kinase receptor TrkB. BDNF binding to TrkB activates several signaling pathways (Kaplan and Miller, 2000) , which subsequently induce biological responses including protection against stress-induced neuronal damage.
The endocannabinoid system represents an important substrate for the control of emotional behavior (Valverde, 2005) . The CB 1 receptor, the most abundant cannabinoid receptor in the brain, is expressed in all of the main brain structures involved in stressrelated behaviours such as the hypothalamus, amygdala, limbic system, habenula, cortex and hippocampus (Matsuda et al, 1993) and participates in the control of the HPA axis (Barna et al, 2004; Patel et al, 2004; Cota et al, 2007) . Moreover, the lack of CB 1 receptor induced neuronal plasticity impairments as demonstrate the loss of neurons (Bilkei-Gorzo et al, 2005) and defective neurogenesis in the hippocampus (Jin et al, 2004 ) and the increased susceptibility to neurotoxic insults described in CB 1 knockout mice (Marsicano et al, 2003) .
The aim of the present study was to investigate the role of the hippocampal BDNF in the emotional responses of mice lacking CB 1 receptor considering the participation of the endocannabinoid system in the stress-related responses and the relevance of the neurotrophic-induced plasticity in the hippocampal response to stressful events.
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Materials and methods
Animals
All the experiments were carried out in male CB 1 knockout mice and wild-type littermates 8-12 weeks old at the beginning of the experiments. The generation of mice lacking CB 1 cannabinoid receptor was described previously (Ledent et al, 1999 
Experimental procedure
Stress exposure
Animals were exposed to the tail suspension test (TST). Mice were individually suspended by adhesive tape 1 cm from the tip of the tail 50 cm above a bench top for a 6 min period as described by Steru et al (1985) . The time that the animal was totally inactive during this period was recorded. After the TST exposure, animals were individually housed and one hour later were killed. Blood samples were collected, and brain areas were dissected and immediately frozen at -80ºC.
Basal measurements of serum corticosterone, BDNF and CREB levels were obtained from CB 1 knockout mice and wild-type littermates which were killed immediately after taking them from their home cage.
BDNF hippocampal microinjection
rhBDNF was locally administered into the hippocampus (0.25 μg/side). Mice were first anaesthetized with a ketamine/xylazine mixture (5:1; 0.10 mL/10 g body weight, i.p.) and subsequently mounted in a stereotaxic frame (KOPF Instruments, Tujunga, CA, U.S.A.). The coordinates (AP: -1.9; ML: ± 1.8, DV: -2.3, expressed in mm) for the cannuli (7 mm long, 30 gauge) implantation into the hippocampus were taken from bregma and the skull surface according to the stereotaxic atlas (Paxinos and Franklin, 1997) . Mice were administered bilaterally into the hippocampus. Each animal received 1 μL/side of vehicle or rhBDNF and 0.2 μL/side of the cell labeling CM-DiI. The infusion was carried out during 5 min and the cannula was removed 2 min after the end of the infusion. In order to evaluate the effect of hippocampal rhBDNF microinjection,
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Aso et al TST was performed, as described previously, three days after the surgery. After TST, mice were killed and the brains were removed and frozen. Coronal sections (40 μm) of the brain were cut on a cryostat at -26ºC and a red fluorescent light was used to reveal the exact location of CM-DiI at the site of infusion, although small amounts of CM-DiI signal were observed in practically all the anterior-posterior length of the hippocampus.
Data from mice with wrong location of the cannuli were removed from the study.
Preparation of samples
Blood samples
Blood samples were allowed to coagulate and were then centrifuged (800 g, 10 min at 4ºC). Serum was recovered and frozen at -80ºC until corticosterone measurements.
Brain areas processing
Frozen brain areas were dounce-homogenized in lysis buffer (137 mM NaCl; 20 mM Tris-HCl, pH 8.0; 1% NP-40; 10% glycerol; 1 mM sodium vanadate; 5 mM sodium pyrophosphate; 100 mM NaF; 40 mM glycerol phosphate; 1mM PMSF; 0.15 μΜ aprotinine; 11 μΜ leupeptine; 1.5 μM pepstatine) in order to prepare protein extract.
Hippocampus and frontal cortex were homogenized in 30 μL lysis buffer/mg wet weight whereas amygdala was homogenized in 50 μL lysis buffer/mg wet weight. After 20 min of incubation in agitation at 4ºC, samples were centrifuged during 30 min at 16000 g, and the supernatant was recovered and stored at -80ºC. Protein content was determined by using the DC Protein Assay (Bio-Rad, Barcelona, Spain) following manufacturer's instructions.
Free-floating brain sections
Mice were deeply anaesthetised by intraperitoneal (i.p.) injection (0.2 mL/10 g body weight) of a mixture of ketamine (100 mg/kg) and xylazine (20 mg/kg) prior to intracardiac perfusion of 4% paraformaldehyde (PFA) in 0.1M Na 2 HPO 4 /NaH 2 PO 4 buffer (PB), pH 7.5, delivered with a peristaltic pump at 19 mL/min for 5 min. Brains were removed and postfixed overnight at 4 ºC in the same fixative solution. Brain freefloating sections (30μm) through the hippocampus were obtained with a vibratome (Leica, France) and kept in a cryoprotection solution containing 30% ethylene glycol, 30% glycerol and 0.1M PB at -20 ºC until they were processed for immunohistochemistry.
Corticosterone levels measurement
Serum corticosterone levels were measured by using the Coat-A-Count ® Rat
Corticosterone (Diagnostic Product Corporation, Los Angeles, CA, USA) which is a solid-phase 125 I radioimmunoassay designed for the quantitative measurement of corticosterone in rodent serum with a lower sensitivity limit of detection of 5.7 ng/mL.
Data were expressed as mean ± SEM.
Neurotrophic quantification
The BDNF Emax TM Immunoassay System (Promega Corporation ® , Madison, WI, USA) was used to quantify the levels of BDNF protein. Prior to each assay, samples were diluted and acid-treated in order to adjust the amount of BDNF to the standard curve and to increase the detectable amount of free BDNF in solution by dissociating it from its proforms or receptors (Okragly and Haak-Frendscho, 1997 30mg/100 mL), and developed by H 2 O 2 addition (0.02%). After processing, the tissue sections were mounted onto gelatin-coated slides and dehydrated through alcohol to xylene for light microscopic examination.
CREB and TrkB protein levels quantification
CREB, phospho-CREB and TrkB levels were quantified by western blotting. Equal amounts of lysates (40-50 μg per lane) were separated by SDS-PAGE (12.5%) before electrophoretic transfer onto PVDF membrane (CREB detection) or nitrocellulose membrane (phospho-CREB and TrkB detection) (Bio-Rad, Spain). Membranes were blocked for 1 hour at room temperature in Tris-buffered saline (TBS) (100 mM NaCl, 10 mM Tris, pH7.4) with 0.1% Tween 20, 1 mM sodium orthovanadate, 1 mM NaF (0.5M) and 5% nonfat milk (CREB detection) or 3% nonfat milk (phospho-CREB 
Statistical analyses
Data were analyzed by two-way ANOVA with genotype and stress exposure or treatment as between factors, followed by one-way ANOVA when required.
Comparisons between genotypes in the TST, NGF and NT-3 levels in the hippocampus and BDNF levels in frontal cortex and amygdala were analyzed by one-way ANOVA.
Comparisons were considered statistically significant when the level of significance was < 0.05.
Results
Enhanced response to stress in CB 1 knockout mice
The exposure to TST induced a higher immobility time in CB 1 knockout mice than in wild-type littermates (F (1, 13) = 9.412, p < 0.01), revealing an increased despair behavior in mice lacking CB 1 receptor (Fig 1A) .
The corticosterone release produced by the exposure to TST was higher in mutant mice than in wild-type animals, although both genotypes exhibited similar levels of serum corticosterone under basal conditions, evidencing an enhanced neuroendocrine response to stress in mutant mice (Fig 1B) . Two-way ANOVA revealed a significant effect of stress exposure (F (1, 28) = 65.819, p < 0.001), genotype (F (1, 28) = 5.012, p < 0.05) and interaction between these two factors (F (1, 28) = 5.336, p < 0.05). Subsequent one-way ANOVA calculated for the response to stress indicated an effect of stress exposure in wild-type (F (1, 14) = 16.640, p < 0.001) and CB 1 knockout mice (F (1, 14) = 54,970, p < 0.001). One-way ANOVA calculated for genotype effect showed higher levels of corticosterone in CB 1 knockout mice exposed to stress compared to wild-type animals (F (1, 12) = 4.754, p < 0.05) but not in basal conditions.
BDNF decreased levels in hippocampus of CB 1 knockout mice
BDNF protein quantification (ELISA)
CB 1 knockout mice showed decreased BDNF levels in the hippocampus at basal conditions (wild-type: 651 ± 51 ng BDNF/g wet weight; CB 1 knockout: 451 ± 37 ng BDNF/g wet weight) and after stress exposure (Fig 2A) , indicating an impairment in the neurotrophic support in mutant mice. Two-way ANOVA revealed a significant effect of stress exposure (F (1, 31) = 72.509, p < 0.001) and genotype (F (1, 31) = 16,511, p < 0.001), but not interaction between these two factors. Subsequent one-way ANOVA indicated an increase of BDNF levels in response to stress in both wild-type (F (1, 16) = 28.060, p < 0.001) and CB 1 knockout mice (F (1, 15) = 84.631, p < 0.001). Comparisons between genotypes revealed lower BDNF levels in CB 1 knockout mice under basal conditions (F (1, 17) = 6.855, p < 0.05) and after stress exposure (F (1, 14) = 9.098, p < 0.001).
The analysis of BDNF content in frontal cortex and amygdala revealed no differences between genotypes (Fig 2C) , suggesting specific brain area BDNF impairment in CB 1 knockout mice.
The neurotrophic deficiency in the hippocampus of CB 1 knockout mice seems to be specific for BDNF since the analysis of other neurotrophic factors such as NGF (wildtype 100.0 ± 8.3; knockout 107.8 ± 10.8) and NT-3 (wild-type 100.0 ± 7.3; knockout 99.9 ± 12.5) indicated no differences between genotypes (Fig 2D) .
Immunohistochemistry
CB 1 knockout mice hippocampal BDNF impairment revealed by ELISA quantification was confirmed by the microscopic examination of the BDNF immunoreactivity in brain sections (Fig. 2B) . The BDNF deficiency was homogeneously observed in the all the areas of the hippocampus.
CREB and TrkB quantification
The analysis of hippocampal samples revealed no differences between genotypes in ratio phospho-CREB/CREB ( Fig. 3A and 3B ) or in the amount of the TrkB receptor (Fig 3A and 3C) . No significant differences were either observed in the total amount of CREB in hippocampal samples (data not shown).
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Reversal of CB 1 knockout increased despair behavior by local BDNF hippocampal microinjection
Local administration of BDNF (0.25 μg/side) into the hippocampus reversed the immobility induced by the TST in both wild-type and CB 1 knockout mice (Fig 4) . Twoway ANOVA indicated a significant treatment effect (F (1, 35) = 17.060, p < 0.001), without genotype effect, nor interaction between these two factors. One-way ANOVA revealed significant reduction in the immobility time of BDNF-treated wild-type (F (1, 17) = 5.511, p < 0.05) and CB 1 knockout mice (F (1, 18) = 11.877, p < 0.01). Comparisons between genotypes showed a significant increase in the immobility time in vehicletreated CB 1 knockout mice (F (1, 18) = 5.075, p < 0.05), but no differences were observed between both groups of BDNF-treated mice.
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Discussion
The present study reveals BDNF impairment in the hippocampus of CB 1 knockout mice. This neurotrophic factor plays a key role in the enhanced response to stress observed in mutant mice since BDNF administration in the hippocampus completely reversed the increased despair behavior exhibited by CB 1 knockout mice in the tail suspension test.
Mice lacking CB 1 receptor exhibited higher immobility time than wild-type littermates when exposed to the TST. This behavioral paradigm is considered to evidence a state of despair related to mood disorders (Nestler et al, 2002) . The participation of CB 1 receptor in the neurobiological mechanisms involved in mood disorders and stress is supported by the present data and previous findings reporting an increased sensitivity of CB 1 mutant mice to exhibit anhedonia after chronic unpredictable mild stress exposure (Martín et al, 2002) , increased passive stress-coping behaviors in the forced swimming test and a higher vulnerability to behavioral inhibition after repeated or acute severe stress (Fride et al, 2005) , among others (Hill and Gorzalka, 2005) . The enhanced despair behavior revealed in CB 1 knockout mice when exposed to a single TST was associated to increased corticosterone serum levels. The hyperactivity of the HPA axis in response to stress reported in this study is in agreement with previous findings (Barna et al, 2004; Urigüen et al, 2004) , and could be due to impairment in the negative feedback regulation of the HPA axis (Cota et al, 2007) .
Accordingly, endogenous cannabinoids inhibit the HPA axis via centrally located CB 1 receptors (Di et al, 2003; Patel et al, 2004) . However, no differences between genotypes were found in the levels of corticosterone under basal conditions, in contrast to a previous study (Urigüen et al, 2004 ). These controversial data should be explained by the different experimental conditions that were considered as baseline in both studies.
Sustained elevations of glucocorticoids have been shown to produce detrimental effects in synaptic plasticity, dendritic morphology (Watanabe et al, 1992 ) and neurogenesis (Warner-Schmidt and Duman, 2006) , even inducing neuronal death (Sapolsky, 2000b) in the hippocampus. In consequence, these hippocampal changes in synaptic connectivity induced by stress might reduce the inhibitory control that this structure exert on the HPA axis, leading to a positive feedback process with pathological consequences that could induce hippocampal volume reduction and cognitive impairments (Radley and Morrison, 2005; Bremner, 2006) . Then, the hyperactivity of the HPA axis in CB 1 knockout mice could be related to the plasticity impairment observed in these mutants.
BDNF modulates plasticity and survival of adult neurons and glia (Huang and Reichardt, 2001) , and directly modifies the HPA axis activity at the hypothalamic level (Givalois et al, 2004) . We describe for the first time a deficit at the protein level of the neurotrophic factor BDNF in the hippocampus of CB 1 knockout mice under basal conditions. Our finding is supported by the recently described reduction of the BDNF mRNA expression on the CA3 sub-field of the hippocampus of CB 1 mutant mice ). An increase in the hippocampal BDNF content in both genotypes was observed in response to stress (TST exposure), in agreement with the rapid induction of BDNF expression previously reported after short stress exposure (Marmigere et al, 2003) . However, BDNF levels were significantly lower in mutants than in wild-type mice in response to stress, highlighting the BDNF impairment in mice lacking CB 1 receptor. The BDNF immunoreactivity of coronal sections through the hippocampus revealed that this impairment was homogenously observed in all the regions of the hippocampus of CB 1 mutants. BDNF was not modified in mutant mice in two other brain areas related with stress regulation, frontal cortex and amygdala, revealing an anatomical specificity for this neurotrophic impairment, in agreement with the reported vulnerability of the hippocampus to the detrimental effect of stress (McEwen, 1999) . The neurotrophic deficiency observed in the hippocampus of CB 1 knockout mice seems to be specific for BDNF since no differences were found in basal conditions in the levels of NGF and NT-3, two additional neurotrophic factors.
Therefore, BDNF is a specific target for the impairment in plasticity induced by stress in CB 1 knockout mice and this neurotrophic factor seems to be a key mediator in the CB 1 receptor-dependent mechanisms of neuroprotection (Khaspekov et al, 2004) . The deficit in BDNF mediated plasticity here reported on CB 1 knockout mice could be related to the loss of neurons in the CA1 and CA3 hippocampus regions of aged mice (Bilkei-Gorzo et al, 2005) and the increased susceptibility to neurotoxic insults (Marsicano et al, 2003) previously described in these mutant mice.
In order to clarify the mechanisms involved in this BDNF impairment, we have investigated in CB 1 knockout mice the possible changes on BDNF receptor and CREB, a transcription factor directly related to BDNF (Conti et al, 2002) . CREB represents a central integrator of signaling from several extracellular stimuli that influence neuronal plasticity and survival (Duman, 2002) . No changes on CREB activity were observed in the hippocampus of CB 1 knockout mice suggesting that the described BDNF impairment is independent of the transcription mechanisms related to CREB. Moreover, BDNF deficit does not produce alterations in the density of TrkB, the specific receptor by which BDNF exerts most of its biological effect (Kaplan and Miller, 2000) .
In order to verify the functional role of the hippocampal BDNF impairment in the enhanced despair behavior exhibited by CB 1 knockout mice, the behavioral effects of a local BDNF microinjection in the hippocampus was evaluated. BDNF reduced the immobility time during the TST in both genotypes, and interestingly, completely reversed the increased despair behavior shown by CB 1 knockout mice. This finding confirms the crucial role played by BDNF on the emotional impairment of these mutants. In spite of the relevance of this behavioral finding, the biochemical mechanisms underlying the link between CB 1 receptor and BDNF can not be yet completely elucidated. We hypothesize that the BDNF impairment here reported could be induced by the hyperactivity of the HPA axis in the absence of the inhibitory effect of the CB 1 receptor. There are evidence showing that BDNF expression is decreased by glucocorticoids (Smith et al., 1995; Schaaf et al., 1998; Jacobsen and Mork, 2006) . The mechanisms by which steroids exert this control on BDNF expression are not completely elucidated, but it has been described that it could be via activated gluco-and mineralocorticoid receptors (Hansson et al, 2000) or inducing sustained extracellular signal-regulated kinase/mitogen-activated protein kinase activation. (Yang et al, 2004 ).
However, other potential explanations are equally probable. Considering a possible CB 1 -dependent activation of the BDNF, the interruption of this signaling cascade in CB 1 knockout mice could first diminish BDNF levels and then the induced plasticity impairment could modify the HPA axis regulation in these mutants.
In summary, our results provide evidence for neurotrophic and neuroendocrine changes in CB 1 knockout mice that could explain the neurobiological substrate underlying the enhanced stress response and despair behavior exhibited by these mutants. We demonstrate that the lack of CB 1 receptor originates a deficiency in the feedback regulation of the HPA axis, which seems to be related to the decreased BDNF levels 
